DIGP - DigiPath, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.26176
+0.00186 (+0.71411%)
At close: 3:53PM EST
Stock chart is not supported by your current browser
Previous Close0.25990
Open0.25200
Bid0.00000 x 0
Ask0.00000 x 0
Day's Range0.24627 - 0.27000
52 Week Range0.14100 - 0.35500
Volume143,632
Avg. Volume146,533
Market Cap8.932M
Beta1.48
PE Ratio (TTM)N/A
EPS (TTM)-0.04500
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • DigiPath, Inc. :DIGP-US: Earnings Analysis: Q3, 2017 By the Numbers : October 5, 2017
    Capital Cube2 months ago

    DigiPath, Inc. :DIGP-US: Earnings Analysis: Q3, 2017 By the Numbers : October 5, 2017

    Categories: Yahoo FinanceGet free summary analysis DigiPath, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of DigiPath, Inc. – Internet of Things Inc. (ITT-CA) that have also reported for this period. Highlights Summary numbers: Revenues of USD 0.39 million, Net Earnings of USD -0.41 million. ... Read more (Read more...)

  • PR Newswire3 months ago

    Digipath, Inc. Enters into Joint Venture to Establish a Cannabis Testing Laboratory in California

    LAS VEGAS, Sept. 25, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis testing laboratory and media firm, is pleased to announce that it has entered into a joint venture with Mr. Don Ashley, an experienced real estate developer and cannabis entrepreneur, to establish and operate a cannabis testing laboratory in California. The joint venture, Humboldt Botanical, LLC, will conduct business under the name "Digipath Botanical Testing" and will launch Digipath's entry into the largest cannabis market in the United States. Pursuant to the joint venture agreement, Mr. Ashley will contribute up to $2 million to fund the build-out and equipping of the testing laboratory, while Digipath will be responsible for managing and supervising the day-to-day operations of the laboratory.  Digipath and Mr. Ashley will be entitled to receive 40% and 60%, respectively, of the joint venture's cash distributions, provided that until Mr. Ashley has received the return of his invested capital, distributions will made 75% to Mr. Ashley and 25% to Digipath.  Digipath has also provided the joint venture with a non-exclusive license to use its intellectual property in connection with the operation of the laboratory.

  • PR Newswire4 months ago

    Digipath, Inc. Announces Third Fiscal Quarter 2017 Results

    LAS VEGAS , Aug. 16, 2017 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP) ("DIGP" or the "Company"), a service oriented independent testing laboratory and media firm focused on the developing ...

  • DigiPath, Inc. :DIGP-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017
    Capital Cube5 months ago

    DigiPath, Inc. :DIGP-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017

    Categories: Yahoo FinanceGet free summary analysis DigiPath, Inc. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of USD 0.50 million, Net Earnings of USD -0.22 million. Gross margins widened from -3.82% to 55.54% compared to the same period last year, operating (EBITDA) margins now -54.46% from -244.57%. Change in operating cash ... Read more (Read more...)

  • PR Newswire5 months ago

    Digipath Receives Recreational Testing License and Renews Medical License as Retail Cannabis Market Launches in Nevada

    LAS VEGAS, July 10, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent testing laboratory and media firm focused on the burgeoning cannabis market, is pleased to announce that it has both received its recreational testing license and renewed its existing medical testing license alongside the launch of the highly anticipated retail cannabis market in Nevada which began on July 1, 2017. Nevada's medical cannabis market currently serves just over 28,000 patients that use the plant and its derivative products for the treatment of a variety of maladies.

  • PR Newswire6 months ago

    Digipath, Inc. to Present at the Southeast Cannabis Conference in Florida

    LAS VEGAS, June 7, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent testing laboratory and media firm focused on the developing cannabis market, is pleased to announce that its President, Todd Denkin, will be a presenter at the Southeast Cannabis Conference on June 11, 2017, in Ft. Lauderdale, FL. Mr. Denkin will be presenting at the session entitled, "Cannabis Testing, Safety & Analytics," where he will be discussing the vital role that cannabis testing plays in the emerging cannabis marketplace, the value that testing and analytics provide to cannabis consumers, and the leadership role that Digipath has achieved in the market.

  • PR Newswire7 months ago

    Digipath, Inc. Announces Second Fiscal Quarter 2017 Results Highlighting 252% Increase in Revenue

    LAS VEGAS, May 12, 2017 /PRNewswire/ -- Digipath, Inc. (OTCQB: DIGP), a growth oriented independent testing laboratory and media firm focused on the developing cannabis market, today announced financial ...

  • PR Newswire7 months ago

    Digipath Appoints Dr. John Abroon to Advisory Board

    NEW YORK, May 3, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis lab testing and media firm, is pleased to announce it has appointed John Abroon, M.D. as the initial member of its Advisory Board. Dr. Abroon is a board-certified general practitioner who specializes in diagnostic and preventative medicine, completing his residency program at Westchester County Medical Center in 1986. Dr. Abroon is affiliated with Mount Sinai and Lenox Hill hospitals and has strong working relationships with prestigious New York specialists at a number of area hospitals and medical facilities.

  • Digipath to Present at Viridian Cannabis Investment Summit in New York City
    PR Newswire9 months ago

    Digipath to Present at Viridian Cannabis Investment Summit in New York City

    NEW YORK, March 22, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis lab testing and media firm, is pleased to announce it will present at the upcoming Viridian Cannabis Investment Summit taking place at the John Jay College of Criminal Justice in New York City on Friday, March 31, 2017. Digipath Chief Science Officer Cindy Orser, Ph.D. will present at this event. Entitled "Cultural Diversity in the Cannabis Industry", this private event will explore opportunities to bring cultural diversity into the cannabis industry by educating and inspiring a more diverse group of professionals and investors to get involved.

  • PR Newswire9 months ago

    Digipath Hires Renowned Ex-NYPD Detective, Richard "Bo" Dietl, as Consultant

    NEW YORK, March 20, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis lab testing and media firm, is pleased to announce it has hired renowned ex-NYPD detective, Mr. Richard "Bo" Dietl, as a consultant. Mr. Dietl was a New York City police officer and detective from June 1969 until he retired in 1985 and is one of the most highly decorated detectives in the history of the police department, with thousands of arrests to his credit. In 1989, President George Bush appointed Mr. Dietl as co-chairman of the National Crime Commission.

  • PR Newswire10 months ago

    Digipath Appoints Dr. Alfredo Axtmayer to Board of Directors

    NEW YORK, Feb. 28, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis lab testing and media firm, is pleased to announce that it has appointed Alfredo Axtmayer, M.D. to its Board of Directors. Dr. Axtmayer is an orthopedic surgeon in Wallingford, Connecticut and is affiliated with multiple hospitals in the area, including Hospital of St. Raphael and MidState Medical Center.

  • PR Newswire10 months ago

    Digipath, Inc. Enters into Joint Venture Agreement with Strategic Investor

    Digipath and the investor intend to open cannabis testing labs in jurisdictions outside of Nevada, with Digipath to provide turnkey services and its industry expertise and the OC Testing to provide all funding required to open such labs. Services to be provided by Digipath will include oversight of the purchase and installation of all laboratory equipment, responsibility for obtaining state and local regulatory approvals, and the identification and hiring of laboratory personnel. Digipath will be entitled to 20% of the cash flow generated by each such lab.

  • PR Newswire10 months ago

    Digipath, Inc. Announces First Fiscal Quarter 2017 Results

    LAS VEGAS, Feb. 14, 2017 /PRNewswire/ --  Digipath, Inc. (OTCBB and OTCQB: DIGP), a growth oriented independent testing laboratory and media firm focused on the developing cannabis market, today announced ...

  • PR Newswire11 months ago

    Digipath to Present on Cannabis Investor Webcast on January 26, 2017

    LAS VEGAS, Jan. 23, 2017 /PRNewswire/-- Digipath, Inc. (DIGP), an independent cannabis lab testing and media firm, is pleased to announce that it will be a presenting company on the upcoming Cannabis Investor Webcast. The Webcast is scheduled to take place on Thursday, January 26, and Digipath is scheduled to present from 12pm ET to 12:45pm ET. You can register for this Webcast by visiting http://www.cannawebcast.com/ and clicking the "Attend" button at the top of the page or by clicking here.

  • PR Newswire11 months ago

    Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies

    The acquisition targets consist of a family-owned laboratory established in 1948, based in Northern New Jersey, providing clinical laboratory services and toxicology testing, and an affiliated fully licensed clinical laboratory operating in New Jersey and Pennsylvania that specializes in toxicology services for pain-management physicians and addiction specialists. Both companies provide a broad range of diagnostic tests (blood, urine, cholesterol, drug) for patients, physicians, nursing homes, assisted living facilities, and drug and alcohol treatment programs and clinics. The diagnostic/pathology lab testing market is estimated to be $65 billion in size, is highly fragmented, and has strong growth characteristics. Digipath believes that the highly fragmented nature of the cannabis testing industry has created substantial consolidation opportunities, and is focused on replicating the Digipath Labs model in other cannabis-legal states, both through organic growth and acquisition.

  • PR Newswire11 months ago

    Digipath Featured in December/January Issue of CannaInvestor Magazine

    LAS VEGAS, Jan. 4, 2017 /PRNewswire/ -- Digipath, Inc. (DIGP), an independent cannabis lab testing and media firm, is pleased to announce that it is featured as an emerging cannabis market leader in the December 2016/January 2017 issue of CannaInvestor Magazine. Digipath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry's best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. Digipath's two business units are Digipath Labs and TNM News Corp. Digipath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy.

  • Marketwiredlast year

    Digipath's President and Chief Science Officer Interviewed in Recent Issue of The Wall Street Transcript

    Digipath, Inc. , an independent cannabis lab testing and media firm, is pleased to announce that Todd Denkin, President and COO of Digipath, and Cindy Orser, Ph.D., Chief Science Officer of Digipath, were ...